Capstone Capital Management Ltd

Position in GILD — Gilead Sciences, Inc.

CIK 2069260 HONG KONG, K3

Position in GILD

as of Jun 30, 2026 · filed Jul 20, 2026 Compact

Position Value

$801,627

+$8,850 QoQ

Shares Held

6,345

-1.8% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.43%

of 13F equity value

Holder Rank

#1,164

of 2,266 holders

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Capstone Capital Management Ltd holds $1,971,934 across 3 Drug Manufacturers - General names. GILD ranks #2 (40.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BMY	Bristol Myers Squibb Co	14,109	$812,960
2	GILD	Gilead Sciences, Inc. This page	6,345	$801,627
3	PFE	Pfizer Inc	14,840	$357,347

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$801,627	6,345	-1.8%	Shares	Sole	2026-07-20
2025-12-31	$792,777	6,459	—	Shares	Sole	2026-02-06
No filing history on record for this holder in this stock.